Tue, Jul 22, 2014, 10:10 AM EDT - U.S. Markets close in 5 hrs 50 mins


% | $
Click the to save as a favorite.

Zynga, Inc. Message Board

pharmaapproved 347 posts  |  Last Activity: 20 hours ago Member since: Jun 7, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • pharmaapproved by pharmaapproved May 17, 2014 7:37 PM Flag


    The lawsuits are pouring in now. I also just seen a commercial on ABC looking for participants to partake in more class action lawsuits. Takeda nearing 5 year lows on the news and recently cut their sales staff by a considerable margin. This doesn't bode well for OREX who;s trying to pull a VIVUS by trying to bring another generic to market. Arena looking like it's going to be the cream of the crop in the obesity space more & more each day!

  • I'm not sure if this has been posted or not. So I thought I would share it with everyone but "Swalchie".

    A study of 509 type 2 diabetes patients found that lorcaserin was more effective than diet and exercise alone in reducing A1C levels regardless of whether the patients lost weight. The patients, randomly assigned to either lorcaserin or placebo along with diet and exercise, had A1c levels between 7% and 10%, as well as similar fasting plasma glucose levels. The researchers defined responders as patients who achieved the primary endpoint of weight loss of at least 5% at 52 weeks of treatment. Presented June 24 at American Association of Nurse Practitioners meeting.

  • And sales are flat to down? That did it for me today so I took the money and ran for probably the last time. To many other companies out there actually making money to sit idle here month after month.

    I'm just to young to sit by for another 2 or 3 years hoping for the best. These past 3 years have been fun and I've learned a lot from some really knowledgeable posters (Dr, Dan, Diogenes, Suave9, Jairy, JDStevens, Hedge Risk, Sharon, even Bemis. I am sure i'm missing a few but GOOD LUCK to you guys.

  • Now covers Belviq as of last week with PA. I thought i'd share the news with you guys being that you probably won't hear about it anywhere else unless you where looking.


  • pharmaapproved by pharmaapproved May 28, 2014 9:21 AM Flag

    He seems to think Belviq cannot be combined/mixed with other weight loss drugs. This is nothing more then pure fud/misleading at best. This is what makes Belviq the better drug for starters because all Vivus & Orex are doing is adding Phen to the mix which OF COURSE is going to show some decent results. Doctors have been prescribing these generic combo's for years and will continue to do so. You don't have to look far and see that Contrave may very well be at risk from generic drug makers. Vivus thought they had the goods under wrap to but after just 1 year the pressure is on by Actavis.

    The facts are maybe Arena can't mix the Belviq + Phen but that doesn't mean Doctors can't! And as a matter of fact Doctors ARE ALREADY are prescribing Belviq and then adding Phen if they chose to. Arena doesn't need a B+P combo because Belviq is a novel agent which neither Vivus or Orex can make claim too. When Doctors do prescribe Belviq + Phen results have shown to be remarkable. Yes results have shown up to 15% reduction in weight loss.

    By the way ANYONE who has ran across Scott M. articles knows he is the PUMP AND DUMP KING!!!

  • Reply to

    Form 4 - Jack Lief

    by keeters34 Jul 3, 2014 6:44 PM
    pharmaapproved pharmaapproved Jul 3, 2014 10:11 PM Flag

    WOW, Why you guys keep defending this company is beyond me. Pre-planned or not this is just totally ridiculous and people wonder why this company is going nowhere fast. It's not like these where expiring options, these where actual shares that he could of held onto until the cows came home. People on this board give folks a hard time for selling but an insider sells over a million dollars worth of stock and it's somehow all honky dory!? I really do wish you longs the best of luck some more than others but until this company is held responsible I would expect the downward draft to continue! And to think a few investors here gave Jack a hard time recently at the yearly meeting and Jack claiming I don't know what to do about the stock price. Well here's an idea, show them a little more faith and put your money where your mouth is rather than dumping on your shareholders time and time again!

  • Management of Obesity in Adults being circulated to thousands of Family practice Doctors across the Country. Follow the link below for 33 pages of good stuff. All the drugs in the space mentioned in great detail.


  • Plan to increase sales representatives from approx. 400 to approx. 600 in July. Plan to expand physician coverage from approx. 65,000 to approx. 90,000
    Launch DRTV toward approx. 720 million potential views; 3.5 times in voucher enrollment and doubled BELVIQCOM site visits
    (Airing throughout the entire year)
    Expand saving card and voucher awareness through print advertisement. Aim 70% level commercial coverage by end of FY2014
    Obesity (Japan) : Submit Clinical Trial Notification/Clinical Trial Application 1Q 2014
    Obesity (China) : Submit to Pharmaceuticals and Medical Devices Agency/China Food and Drug Administration 1Q 2014
    Smoking Cessation
    Initiated phase II study April 2014
    Completion anticipated in FY2014
    Still waiting to hear from Canada & Mexico

  • pharmaapproved by pharmaapproved Jun 11, 2014 5:33 PM Flag

    Arena in the cross hairs of somebody. Mentioned Glasko!

  • Reply to

    Wells Fargo take on OREX delay

    by sharonconk Jun 11, 2014 8:09 AM
    pharmaapproved pharmaapproved Jun 11, 2014 8:41 AM Flag

    An analyst on the Orex call this morning has the same question about there patent and OREX literally danced around the question. They know they're in trouble.

    Takede can't be happy with the news that Vivus has already been notified their being challenged by a generic.

  • pharmaapproved by pharmaapproved Jul 13, 2014 7:32 PM Flag

    A Belviq commercial just now. Now there's a good target to hit.

  • Reply to

    Annual Shareholder's Meeting update

    by jdsstevens55 Jun 13, 2014 7:41 PM
    pharmaapproved pharmaapproved Jun 13, 2014 9:03 PM Flag

    Again JD your summary is much appreciated. I can't help but wonder what the beefed up security was about.

  • pharmaapproved by pharmaapproved Jul 1, 2014 9:33 AM Flag

    This popular new weight loss surgery procedure is becoming increasingly sought after both here in Australia and overseas, and with the Maestro Vagal Blocking system having recently been endorsed by the U.S. Food and Drug Administration (FDA) we can expect to hear a lot more about VBLOC over the coming years.
    A major advantage of this system is that the normal anatomy in the abdomen is not altered. There is no restriction of the stomach so there is no restriction of the type of foods that can be eaten. They are just eaten in smaller quantities.

    First released in 2011 by a company called EntereoMedics, VBLOC therapy is delivered by a pacemaker-like device called the Maestro Rechargeable System, a system designed to control hunger and fullness by blocking the primary nerve which regulates our digestive system. However it wasn't until this year that truly solid data was available on the true efficacy of this groundbreaking technology.

    The clinical trials involved patients in the US and Australia, and Maestro was found to be an incredibly effective weight loss treatment.

  • Reply to

    Must see, good for a laugh

    by nyccapecod Jun 11, 2014 7:44 AM
    pharmaapproved pharmaapproved Jun 11, 2014 7:53 AM Flag

    Adam said "" If FDA allows cardiovascular outcomes data favorable to Contrave to be included in the weight loss drug's label".

    That's a big "IF" and he knows it. Orex tried to push this through without the full study and it's going to cost them. Adam just trying to save face for him and his buddies who need to escape.

  • pharmaapproved by pharmaapproved Jun 11, 2014 10:18 AM Flag

    I'm back in.

  • pharmaapproved by pharmaapproved May 24, 2014 8:42 AM Flag

    You calling people idiots, dumb and a few other words I've seen you post recently is pretty pathetic. I won't call you an idiot but your charts sure make you look like one. I don't believe your charts have ever been right. As a matter of fact the PPS seems to always drop when you make your fantasy video's. One day you'll realize charts don't work here yet. The only thing that matters now is BELVIQ sales and how to figure out how to pay for the pipeline if BELVIQ isn't a blockbuster by this time next year.

  • Reply to

    AdamF new tweet is BS

    by ahc1111 May 9, 2014 9:13 AM
    pharmaapproved pharmaapproved May 9, 2014 9:25 AM Flag

    I'm sorry I ever tried defending that guy. I thought for sure he changed his view of Arena & Eisia. Him saying or anyone else saying " adding new reps is a sign of failure" should have their head examined. That is so backwards thinking!

  • pharmaapproved pharmaapproved Jun 11, 2014 8:33 AM Flag

    His ego is hurting and I would be prepared for him the unleash hell on this stock as if he doesn't already.

  • It has been heavily edited leaving out a majority of what was actually said. No replay of the video leaves you scratching your head. Now let the conspiracy live on because something #$%$ stinks and it ain't me I checked!!

  • Believe it or not this used to be a good board with valuable information. Two year old kids act more grown than what I have seen around here as of late. Sad, pitiful, but true!

3.08-0.02(-0.65%)10:10 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.